Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Exostar’s Life Sciences Cloud Collaboration Platform Exceeds Growth Objectives

Published: Friday, February 21, 2014
Last Updated: Friday, February 21, 2014
Bookmark and Share
Life Sciences Identity Hub Tops 500 Organizations and 10,000 Users in First Year

Exostar, whose cloud-based solutions enable secure, cost-effective business-to-business collaboration, has announced significant milestones in the adoption of its community cloud access and collaboration service offering for the Life Sciences industry.  Led by two of the ten largest global pharmaceutical companies, more than 500 organizations supporting over 10,000 individuals in 46 countries on six continents are leveraging Exostar’s Life Sciences Identity Hub and Secure Access Manager (SAM) to safely, securely, and cost-effectively collaborate in the cloud.

Exostar’s solutions are an enabler that supports the transformation of the drug research and development (R&D) process.  Rather than go it alone, companies are embracing a partner-centric R&D model that speeds time-to-market for new drugs and therapies.  Exostar’s community offering in the cloud addresses three key business tenets:

    Connect once (to access applications across enterprise boundaries)
    Collect once (to share partner attribute information with relying parties)
    Certify once (to reduce the cost of multiple audits)

The Exostar Life Sciences Identity Hub brings together organizations and their systems, applications, and information.  The cloud-based Identity Hub, delivered as-a-Service, eliminates the need for companies including manufacturers, clinical research organizations, and academic institutions to establish and maintain costly, redundant point-to-point interactions, freeing critical IT resources and budgets.

SAM provides employees of connected organizations with single sign-on access, using their existing credentials, to a growing list of more than 20 enterprise-class applications both on-premise and in the cloud.  SAM controls user access through strong authentication of identities, along with enforcement of the roles and privileges assigned and updated by system, application, and information owners.

Exostar teams with stakeholders in the community to define and refine the Life Science Identity Hub’s processes, rules, and governance terms that provide the flexibility and accountability necessary to ensure compliance with corporate, industry, and Government regulatory requirements, while protecting intellectual property and sensitive information from compromise.  The Life Sciences service offering builds on Exostar’s expertise in delivering similar capabilities to the Aerospace and Defense marketplace, where the community encompasses nearly 100,000 organizations and 300,000 users in 150 countries.

“Our solution is allowing Life Sciences organizations to more quickly establish new relationships, strengthen existing relationships, and reduce IT costs,” said Vijay Takanti, Exostar’s Vice President of Security and Collaboration Solutions.  “By reducing the time it takes these organizations to begin collaborating productively with their external partners from months to days, we are helping streamline the drug R&D process – driving new revenue streams for our customers while bringing life-altering drugs and therapies to market sooner.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Parexel Connects to Exostar’s Life Sciences Cloud Collaboration Platform
Clinical Research Organization Joins Growing Community to More Efficiently and Effectively Partner with its Customers
Tuesday, March 11, 2014
Scientific News
Emerging Model of Cancer
Cancer acts cooperatively, making individual decisions but acting in unison; this insight is being used to create a computer model of cancer.
Personalised Medicine: Dose by Design
Personalised medicine holds the promise of a new approach to healthcare, tailored exactly to our individual needs, as Congenica's Nick Lench discussed on a recent BBC Radio 4 programme.
Expanding Knowledge of Viral Diversity
Environmental datasets help researchers double the number of microbial phyla known to be infected by viruses.
Computers Better Predict Lung Cancer Type, Severity
Study shows automating the analysis of cancer tissue samples increases the accuracy of tumor classification and patient prognoses.
Using Big Data to Discover Potential Cancer Biomarkers
University of Hawai'i Cancer Center researchers used "Big Data" to discover potential cancer biomarkers, a panel of six long intergenic non-coding RNAs (lincRNAs), for the diagnosis of all types of cancers including lung, breast, prostate, liver and ovarian cancers.
Protecting Privacy in Genomic Databases
System helps ensure databases used in medical research will not leak patients’ personal information.
Algorithm To Find Precise Cancer Treatments For Patients Developed
The JAMMIT algorithm could help predict which patients will benefit most from chemotherapy.
Depression Genetics Insight from Crowd-Sourced Data
Genome sites liked to depression have been discovered from data shared by people who had purchased their genetic profiles online.
Detecting Hazardous Chemicals in Complex Mixtures
Researchers are pioneering a new chemical substance analyis software technique that could increase illicit substance detection.
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!